316
Views
4
CrossRef citations to date
0
Altmetric
CASE REPORT

A Behçet Case with Renal Amyloidosis

, , &
Pages 323-326 | Published online: 07 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

M.D. Redondo-Pachón, R. Enríquez, A.E. Sirvent, E. Andrada, R. Noguera-Pons, I. Millán & F. Amorós. (2013) Tocilizumab Treatment for Nephrotic Syndrome Due to Amyloidosis in Behcet’s Disease. Renal Failure 35:4, pages 547-550.
Read now

Articles from other publishers (3)

Guzin Karatemiz, Sinem Nihal Esatoglu, Mert Gurcan, Yesim Ozguler, Sebahattin Yurdakul, Vedat Hamuryudan, Izzet Fresko, Melike Melikoglu, Emire Seyahi, Serdal Ugurlu, Huri Ozdogan, Hasan Yazici & Gulen Hatemi. (2023) Frequency of AA amyloidosis has decreased in Behçet’s syndrome: a retrospective study with long-term follow-up and a systematic review. Rheumatology 62:1, pages 9-18.
Crossref
Tekin Akpolat, Melda Dilek, Kenan Aksu, Gökhan Keser, Ömer Toprak, Mustafa Ci̇ri̇t, Yusuf Oğuz, Hülya Taşkapan, Zelal Adibelli̇, Harun Akar, Bülent Tokgöz, Mustafa Arici, Hüseyin Çeli̇ker, Banu Di̇ri̇ & Ilkser Akpolat. (2008) Renal Behçet's Disease: An Update. Seminars in Arthritis and Rheumatism 38:3, pages 241-248.
Crossref
Mona Saba, Aline Tohmé, Gérard Abadjian, Fady Haddad & Elie Ghayad. (2005) Amyloses multisystémiques. La Presse Médicale 34:9, pages 640-646.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.